TAFASITAMAB vs TALAZOPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TAFASITAMAB vs TALAZOPARIB: Safety Overview
| Metric | TAFASITAMAB | TALAZOPARIB |
|---|---|---|
| Total FAERS Reports | 1,392 | 1,477 |
| Deaths Reported | 475 | 278 |
| Death Rate | 34.1% | 18.8% |
| Hospitalizations | 433 | 553 |
| Average Patient Age | 70.0 yrs | 60.1 yrs |
| % Female Patients | 50.1% | 55.7% |
| FDA Approval Date | N/A | Jun 20, 2023 |
| Manufacturer | Incyte Corporation | Pfizer Laboratories Div Pfizer Inc |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Discontinued |